ConvaTec Group PLC (LON:CTEC) Receives Average Recommendation of “Buy” from Analysts

ConvaTec Group PLC (LON:CTEC) has earned a consensus recommendation of “Buy” from the six ratings firms that are currently covering the stock, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is GBX 318.67.

CTEC has been the topic of several recent research reports. UBS Group restated a “buy” rating and issued a GBX 375 price target on shares of ConvaTec Group in a research report on Friday, November 7th. Berenberg Bank dropped their target price on ConvaTec Group from GBX 335 to GBX 330 and set a “buy” rating on the stock in a report on Tuesday, August 19th. Royal Bank Of Canada raised ConvaTec Group to an “outperform” rating and decreased their price target for the stock from GBX 320 to GBX 315 in a report on Thursday, August 21st. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of ConvaTec Group in a research report on Friday, November 14th. Finally, Peel Hunt reissued an “add” rating and issued a GBX 270 price objective on shares of ConvaTec Group in a research note on Thursday, November 13th.

ConvaTec Group Trading Down 0.3%

LON CTEC opened at GBX 226.61 on Tuesday. The firm’s fifty day moving average is GBX 238.54 and its two-hundred day moving average is GBX 249.11. ConvaTec Group has a one year low of GBX 218 and a one year high of GBX 311.20. The company has a debt-to-equity ratio of 85.32, a quick ratio of 0.96 and a current ratio of 2.26. The firm has a market cap of £4.43 billion, a PE ratio of 21.38, a P/E/G ratio of 0.93 and a beta of 0.64.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.